Acute Respiratory Distress Syndrome (ARDS) pada Pneumonia COVID-19

Arie Zainul Fatoni, Ramacandra Rakhmatullah

Abstract


Coronavirus disease 2019 (COVID-19) merupakan penyakit pernafasan akut yang ditandai dengan pneumonia dan gagal paru-paru. Agen penyebab COVID-19 telah dikonfirmasi sebagai virus korona baru, yang sekarang dikenal sebagai severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Acute respiratory distress syndrome (ARDS) adalah salah satu komplikasi COVID-19 yang paling sering dengan angka kematian yang cukup tinggi. ARDS muncul sebagai salah satu gambaran disfungsi organ pada fase hiperinflamasi COVID-19. Patofisiologi dan manifestasi klinis ARDS yang disebabkan COVID-19 memiliki perbedaan dengan ARDS pada umumnya. Oleh sebab itu, kami merekomendasikan manajemen ARDS pada COVID-19 disesuaikan dengan tipe ARDS yang terjadi sehingga dapat memperoleh luaran yang baik


Keywords


ARDS; Covid-19; pneumonia;

Full Text:

PDF

References


Mcelroy MC, River C, International L. Coronavirus ARDS ( CARDS ) – Healing a Broken Lung. 2020;(May).

Shang Y, Pan C, Yang X, et al. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care. 2020;10(1):1-24. doi:10.1186/s13613-020-00689-1

Li R, Liu H, Qi H, et al. Lung ultrasound assessment of acute respiratory distress syndrome caused by coronavirus disease 2019: An observational study. Hong Kong J Emerg Med. 2020. doi:10.1177/1024907920969326

Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54-56.e1. doi:10.5694/mja2.50674

Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24(1):1-3. doi:10.1186/s13054-020-02880-z

Fan E, Del Sorbo L, Goligher EC, et al. An official American Thoracic Society/European Society of intensive care medicine/society of critical care medicine clinical practice guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2017;195(9):1253-1263. doi:10.1164/rccm.201703-0548ST

Marino Pl. Acute Respiratory Distress Syndrome. In: Marino’s, The ICU Book,. 4th ed. Philadelphia: : Wolters Kluwer Health / Lippincott Williams & Wilkins; 2014.

Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: The Berlin definition. JAMA - J Am Med Assoc. 2012;307(23):2526-2533. doi:10.1001/jama.2012.5669

Riviello ED, Kiviri W, Twagirumugabe T, et al. Hospital incidence and outcomes of ARDS using the Kigali modification of the Berlin definition. Am J Respir Crit Care Med. 2015;193(1):52–59.

Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;8(12):1201-1208. doi:10.1016/S2213-2600(20)30370-2

Pierrakos. Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options. J Clin Med Res. 2012;4(1):7-16. doi:10.4021/jocmr761w

Yuefei J, Yang H, Ji W, Wu W, Chen S, Duan G. Intuition on virology, epidemiology, pathogenesis, and control of COVID-19. Nov Res Microbiol J. 2020;4(5):955-967. doi:10.21608/nrmj.2020.118446

Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020;(December). doi:10.1038/s41579-020-00459-7

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70. doi:10.1016/j.cytogfr.2020.05.002

Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’’ in COVID-19.’ J Infect. 2020;80(6):607-613. doi:10.1016/j.jinf.2020.03.037

Khiali S, Khani E, Entezari-Maleki T. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome. J Clin Pharmacol. 2020;60(9):1131-1146. doi:10.1002/jcph.1693

Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255-2273. doi:10.1056/nejmra2026131

Jin-Soo Kim, Justin Sangwook Ko SB, Hyungtae Kim and SYL. Cervical Plexus Block 2018 Korean. Korean J Anesthesiol. 2018;August 71(4):274-288. doi:https://doi.org/10.4097/kja.d.18.00143

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109(February):102433. doi:10.1016/j.jaut.2020.102433

Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. Lancet Infect Dis. 2020;20(5):515-516. doi:10.1016/S1473-3099(20)30235-8

Sherren PB, Ostermann M, Agarwal S, Meadows CIS, Ioannou N, Camporota L. COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review. Br J Anaesth. 2020;125(6):912-925. doi:10.1016/j.bja.2020.08.050

Desai J, Moustarah F. Pulmonary Compliance. In: StatPearls. StatPearls Publishing, Treasure Island (FL).

Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099-1102. doi:10.1007/s00134-020-06033-2

Aoyama H, Uchida K, Aoyama K, et al. Therapeutic Interventions and Lung Protective Ventilation in Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-analysis. JAMA Netw Open. 2019;2(7):E198116. doi:Published 2019 Jul 3. doi:10.1001/jamanetworkopen.2019.8116

Robbaa C, Denise Battaglinia B, Lorenzo Balla B, et al. Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. 2020;(January).

Wiener-Kronish JP, E. ABJ, Eikermann CJ, Matthias PC, Quraishi SA. Critical Care Handbook of the Massachusetts General Hospital. Sixth edit. Philadelphia.: Lippincott Williams & Wilkins, a Wolters Kluwer business; 2016.

Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Vol 46. Springer Berlin Heidelberg; 2020. doi:10.1007/s00134-020-06022-5

Pardo E, Constantin JM, Bonnet F, Verdonk F. Nutritional support for critically ill patients with COVID-19: New strategy for a new disease? Anaesth Crit Care Pain Med. 2020;39(6):738-739. doi:10.1016/j.accpm.2020.10.002

Burhan E, Susanto AD, Isbaniah F, et al. PEDOMAN TATALAKSANA COVID-19. Edisi 3. Jakarta; 2020.

Marik P, Sa FCP, Frcp C. An overview of the MATH + and I-MASK + Protocols A Guide to the Management of COVID-19 HOWEVER , TIMING IS CRITICAL. 2020;501(C):1-48.

McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Vol 40.; 2016. doi:10.1177/0148607115621863

Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200-2211. doi:10.1007/s00134-020-06192-2

Thompson BT, Chambers RC, Liu KD. Acute Respiratory Distress Syndrome B. N Engl J Med. 2017;377:562-572. doi:10.1056/NEJMra1608077

Sembroski E, Sanghavi D, Bhardwaj A. Inverse Ratio Ventilation. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-.

Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA Insights. 2020;323(22):2329-2330. doi:10.1186/cc2392




DOI: http://dx.doi.org/10.21776/ub.jap.2021.002.01.02

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.